01 5Onon
02 2Onon Capsules
03 1Onon Dry Syrup
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 28
2019 Revenue in Millions : 36
Growth (%) : -24
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2021 Revenue in Millions : 31
2020 Revenue in Millions : 26
Growth (%) : 28
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2022 Revenue in Millions : 20
2021 Revenue in Millions : 31
Growth (%) : -36
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2023 Revenue in Millions : 5
2022 Revenue in Millions : 20
Growth (%) : -73
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2017 Revenue in Millions : 91
2016 Revenue in Millions : 112
Growth (%) : -19
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 66
2017 Revenue in Millions : 86
Growth (%) : -23%
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 35
2018 Revenue in Millions : 41
Growth (%) : -14
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 22
2018 Revenue in Millions : 25
Growth (%) : -11
LOOKING FOR A SUPPLIER?
